Angela M Reiersen

10PUBLICATIONS
35CO-AUTHORS
Pharmaceutical delivery technologiesToxicology (incl. clinical toxicology)Medical physiology not elsewhere classifiedLearning, motivation and emotionVenereology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 04, 2025
High-Frequency, At-Home Monitoring of Drug Safety and Tolerability in Clinical Trials: Results From Studies of Fluvoxamine for COVID-19 Treatment.

Eric J Lenze, Madeline Nykamp, J Philip Miller

|Nov 21, 2024
Sertraline modulates hippocampal plasticity via sigma 1 receptors, cellular stress and neurosteroids.

Yukitoshi Izumi, Angela M Reiersen, Eric J Lenze

|Oct 19, 2024
Diagnostic Criteria for Primary Tic Disorders: More Reappraisal.

Kevin J Black, Sarah C Grossen, Amanda L Arbuckle

|Jun 03, 2024
Fluvoxamine and long COVID: Post-acute recovery.

Angela M Reiersen, Charles F Zorumski, Eric J Lenze

|Aug 25, 2023
The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients With Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial.

Angela M Reiersen, Caline Mattar, Rachel A Bender Ignacio

|Feb 03, 2023
SSRIs differentially modulate the effects of pro-inflammatory stimulation on hippocampal plasticity and memory via sigma 1 receptors and neurosteroids.

Yukitoshi Izumi, Angela M Reiersen, Eric J Lenze

Pageof 2

Frequent Collaborators

4 joint publications

Eric J Lenze

3 joint publications

Charles F Zorumski

2 joint publications

Shelley N Facente

2 joint publications

David R Boulware